Assessment of Role of Bisphosphonates on Dental Implant Treatment in Post‑menopausal Ladies

Abstract

Objectives: To examine the impact of bisphosphonates (BPs) on dental implant treatment and alveolar bone in post‑menopausal ladies. Materials and Methods: Twenty post‑menopausal ladies who had at least one dental implant within the previous 5 years participated in the current study. Ten subjects were categorized into two groups: Group A had BP medication for 1.5 years, and group B received parathyroid hormone (PTH). Both groups’ bone thickness and bone mineral density (BMD) were measured. Result: Group A had 5%, and group B had 5% of dental implants failures. BMD of cortical bone was 1468 ± 136 mg/mL and 1008 ± 84 mg/mL in groups A and B, correspondingly. The cortical and cancellous bone densities in both the groups were statically significant. Cortical bone thickness was insignificant in comparison. Conclusion: Both cortical and cancellous bones’ bone mineral density decreased in both groups. With continued usage of BPs, the cortical bone thickness increased.